Sort
10,766 grants matching “checkpoint inhibitor”
Dissecting the source and mechanisms of IL-17-mediated modulation of pancreatic tumorigenesis
$370,575Florencia McAllister · University Of Tx Md Anderson Can Ctr · R37 · FY2022 · CA
Harnessing Aurora kinase inhibitionâinduced cell death to enhance immunotherapy in HPVâdriven cancers
$370,575Faye Johnson · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Dissecting and targeting mechanisms of genomic instability-triggered immune evasion in RBM10-deficient non-small cell lung cancer
$370,575Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Understanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer
$370,575Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Harnessing Aurora kinase inhibitionâinduced cell death to enhance immunotherapy in HPVâdriven cancers
$370,575Faye Johnson · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$370,552Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2019 · CA
Project 2: Targeting DNA replication in BRCA-associated breast cancer
$370,550Bing Xia · Rbhs -Cancer Institute Of New Jersey · P01 · FY2021 · CA
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
$370,513Tracy L McGaha · University Health Network · R01 · FY2025 · CA
Skeletal survivorship and immune therapy: The effects of nivolumab on bone metabolism in renal cell carcinoma
$370,511Kendall Moseley · Johns Hopkins University · R21 · FY2019 · AR
Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma
$370,500Roger S Lo · University Of California Los Angeles · R01 · FY2020 · CA
Develop a Therapeutic Nano-vaccine against Head and Neck Cancer
$370,500Yu Leo Lei · University Of Michigan At Ann Arbor · R01 · FY2021 · DE
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2020 · CA
Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma
$370,500Roger S Lo · University Of California Los Angeles · R01 · FY2019 · CA
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2018 · CA
Targeted therapies in cutaneous melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2020 · CA
Develop a Therapeutic Nano-vaccine against Head and Neck Cancer
$370,500Yu Leo Lei · University Of Michigan At Ann Arbor · R01 · FY2019 · DE
Develop a Therapeutic Nano-vaccine against Head and Neck Cancer
$370,500Yu Leo Lei · University Of Michigan At Ann Arbor · R01 · FY2020 · DE
Targeted therapies in cutaneous melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2021 · CA
Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma
$370,500Roger S Lo · University Of California Los Angeles · R01 · FY2021 · CA
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2021 · CA
Regulation of GLI1, a synthetic lethal target of SMARCA4-deficiency, in lung adenocarcinoma
$370,338James Kim · Ut Southwestern Medical Center · R01 · FY2024 · CA
Robust-to-fragile transitions of a phase-separated mitotic organelle in triple-negative breast cancer
$370,150P. Todd Stukenberg · University Of Virginia · U54 · FY2022 · CA
Re-activating Memory T Cells in the Microenvironment of Human Tumors
$370,088Richard B Bankert · State University Of New York At Buffalo · R01 · FY2008 · CA
Translational Events in Platelets
$370,013Andrew Scott Weyrich · University Of Utah · R01 · FY2012 · HL
Project 1: Targeting Metabolic Dependencies in PDAC
$369,941Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2018 · CA